SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Arbutus Biopharma Q1 EPS $(0.25) Beats $(0.39) Estimate, Sales $1.491M Beat $220.000K Estimate

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.250) per share which beat the analyst consensus estimate of $(0.390) by 35.9 percent. This is a 46.81 percent increase over losses of $(0.470) per share

Benzinga · 05/11/2020 10:25

Arbutus Biopharma (NASDAQ:ABUS) reported quarterly losses of $(0.250) per share which beat the analyst consensus estimate of $(0.390) by 35.9 percent. This is a 46.81 percent increase over losses of $(0.470) per share from the same period last year. The company reported quarterly sales of $1.491 million which beat the analyst consensus estimate of $220.000 thousand by 577.73 percent. This is a 113.00 percent increase over sales of $700.000 thousand the same period last year.